Unified Airway Model

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-16

Study Completion Date

2020-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic rhinosinusitis (CRS) impacts approximately 5% of Canadians. CRS patients suffer from a combination of symptoms that include facial pain, nasal obstruction, hyposmia and mucopurulence discharge. Asthma may additionally worsen quality of life and many patients suffer from both conditions. The unified airway model illustrates a link between both conditions as tissue from the middle ear to the sinus cavity to the lungs function as one unit. Despite evidence for the unified airway model in the setting of CRS and asthma, there are no studies to our knowledge that have evaluated the microbiome (the resident microbes and their genetic expressions that affect disease) of the upper and lower airways in this patient population. Determining the microbiome of the upper and lower airways in patients suffering from CRS and asthma will further support the unified airway model but more importantly, will help contribute to understanding the pathophysiology of this inflammatory process and may help guide future management.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Therapeutic Relevance of Abnormal Airway Morphology in Asthma

NCT06970080

Asthma

RECRUITING PHASE4

Airway Remodeling and Rhinovirus in Asthmatics

NCT05775952

Asthma Respiratory Disease

RECRUITING

Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?

NCT00509197

Asthma

TERMINATED NA

Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma

NCT06270576

Asthma; Eosinophilic Asthma

NOT_YET_RECRUITING PHASE1

Airway Inflammation and Disease Burden in Asthmatic Smokers

NCT02833727

Asthma

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Rhinosinusitis (Diagnosis) Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CRS with Asthma

No interventions assigned to this group

CRS without Asthma

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 19 years or older
* Able to speak and understand English
* Diagnosed with chronic rhinosinusitis with or without asthma and COPD or with a sinonasal tumor
* Undergoing sinus surgery in St Paul's Hospital

Exclusion Criteria

* Oral antibiotics in the past month prior to surgery;
* Immunocompromised;
* Prior lung transplants;
* Known sinonasal or bronchial tumors, current or previous;
* Smoking;
* Known bleeding disorders:
* Deemed unfit by the rhinologists/respirologist for bronchoscopy.

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No